Chigusa Morizane

21PUBLICATIONS
126CO-AUTHORS
Social epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 31, 2026
Distinct epidemiology and treatment outcomes between skeletal and extraskeletal Ewing sarcoma in Japan: a population-based study.

|May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors.

|Jan 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

|Oct 19, 2025
Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-B study).

Takeshi Terashima, Chigusa Morizane, Akihiko Chida

|Aug 12, 2025
Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 study.

Lin Shen, Huaxin Duan, Takamichi Kuwahara

|Jul 17, 2025
Epidemiologic Features and Age-Related Differences in Management among Patients with Gastrointestinal Stromal Tumors in Japan: A National Cancer Registry Study.

Hidekazu Hirano, Yoichi Naito, Toshirou Nishida

Pageof 4

Frequent Collaborators

7 joint publications

Makoto Ueno

6 joint publications

Naohiro Okano

6 joint publications

Masafumi Ikeda

6 joint publications

Takayuki Yoshino